WallStreetZenWallStreetZen

NASDAQ: TXG
10x Genomics Inc Stock Ownership - Who owns 10x Genomics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have 10x Genomics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Sarah A. TeichmannDirector2026-08-142,273$57.15
$129.90kSell
Sarah A. TeichmannDirector2026-08-135,278$57.29
$302.38kSell
John R. StuelpnagelDirector2026-08-1117,000$57.58
$978.88kSell
John R. StuelpnagelDirector2026-08-113,000$58.73
$176.18kSell
Serge SaxonovChief Executive Officer2026-06-228,527$33.29
$283.86kSell
Serge SaxonovChief Executive Officer2026-06-229,991$34.28
$342.51kSell
Serge SaxonovChief Executive Officer2026-06-229,821$35.32
$346.84kSell
Serge SaxonovChief Executive Officer2026-06-221,661$36.17
$60.07kSell
Shehnaaz SulimanDirector2026-06-165,359$32.59
$174.64kSell
Shehnaaz SulimanDirector2026-06-16364$33.27
$12.11kSell

1 of 3

TXG insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TXG insiders and whales buy or sell their stock.

TXG Shareholders

What type of owners hold 10x Genomics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Paladin Capital Management LLC4.31%5,617,583$358.80MInsider
Bryan E. Roberts3.33%4,336,630$276.98MInsider
Softbank Vision Fund Aiv M2 LP2.94%3,836,232$245.02MInsider
Venrock Associates VI LP1.56%2,037,825$130.16MInsider
Serge Saxonov0.91%1,180,024$75.37MInsider
Foresite Capital Management I LLC0.40%514,883$32.89MInsider
Benjamin J. Hindson0.39%502,000$32.06MInsider
Adam Taich0.29%379,898$24.26MInsider
John R. Stuelpnagel0.27%348,436$22.25MInsider
Mathai Mammen0.14%180,259$11.51MInsider

1 of 3

TXG vs Health Information Service Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TXG0.10%14.98%Net SellingNet Selling
HQY0.11%65.64%Net SellingNet Selling
HNGE0.07%5.74%Net SellingNet Selling
MMED0.01%90.72%Net SellingNet Selling
BTSG0.10%51.89%Net SellingNet Selling
View Top Health Information Service Stocks

10x Genomics Stock Ownership FAQ

Who owns 10x Genomics?

10x Genomics (NASDAQ: TXG) is owned by 0.10% institutional shareholders, 14.98% 10x Genomics insiders, and 84.93% retail investors. Paladin Capital Management LLC is the largest individual 10x Genomics shareholder, owning 5.62M shares representing 4.31% of the company. Paladin Capital Management LLC's 10x Genomics shares are currently valued at $365.82M.

If you're new to stock investing, here's how to buy 10x Genomics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.